Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Jan 9.
Published in final edited form as: Arch Iran Med. 2014 Apr;17(4):246–252.

Endoscopic Screening for Precancerous Lesions of the Esophagus in a High Risk Area in Northern Iran

Gholamreza Roshandel 1,2, Masoud Khoshnia 2, Masoud Sotoudeh 1, Shahin Merat 1, Arash Etemadi 1,3, Arash Nickmanesh 1, Alireza Norouzi 2, Akram Pourshams 1, Hossein Poustchi 1, Shahryar Semnani 2, Fatemeh Ghasemi-Kebria 2, Roya Noorbakhsh 1, Christian Abnet 3, Sanford M Dawsey 3, Reza Malekzadeh 1
PMCID: PMC5759310  NIHMSID: NIHMS931902  PMID: 24724600

Abstract

Background

Esophageal squamous cell carcinoma (ESCC) is a major health problem in many developing countries, including Iran. ESCC has a very poor prognosis, largely due to late diagnosis. As a first step in developing an early detection and treatment program, we conducted a population-based endoscopic screening for ESCC and its precursor lesion, esophageal squamous dysplasia (ESD), in asymptomatic adults from Golestan Province, northern Iran (a high-risk area for ESCC) to evaluate the feasibility of such a program and to document the prevalence and risk factor correlates of ESD.

Methods

This cross-sectional study was conducted among participants of the Golestan Cohort Study (GCS), a population-based cohort of 50,000 adults in eastern Golestan Province. Randomly selected GCS participants were invited by telephone. Those who accepted were referred to a central endoscopy clinic. Eligible subjects who consented were asked to complete a brief questionnaire. Detailed information about selected risk factors was obtained from the GCS main database. Endoscopic examination with was performed with Lugol’s iodine staining; biopsies were taken from unstained lesions as well as the normally stained mucosa of the esophagus, and the biopsies were diagnosed by expert pathologists according to previously described criteria.

Results

In total, 1906 GCS subjects were invited, of whom only 302 (15.8%) were successfully enrolled. Esophagitis (29.5%) and ESD (6.0%) were the most common pathological diagnoses. Turkmen ethnicity (adjusted OR=8.61; 95% CI: 2.48–29.83), being older than the median age (OR=7.7; 95% CI: 1.99–29.87), and using deep frying cooking methods (OR=4.65; 95% CI: 1.19–18.22) were the strongest predictors for ESD. There were significant relationships between esophagitis and smoking (p-value<0.001), drinking hot tea (P value=0.02) and lack of education (P value=0.004).

Conclusion

We observed a low rate of participation in endoscopic screening. The overall prevalence of ESD was 6.0%. Developing non-endoscopic primary screening methods and screening individuals with one or more risk factors may improve these rates.

Keywords: Esophageal squamous cell carcinoma, endoscopic screening, northern Iran

Introduction

Esophageal cancer is the 8th most common cancer and the 6th most common cause of death from cancer worldwide.1 High incidence rates of esophageal cancer have been reported across central Asia -from northern Iran to north-central China.24 Esophageal squamous cell carcinoma (ESCC) is the most common histological type of esophageal cancer, especially in the developing world.5,6 ESCC typically occurs by progression from a precursor lesion: esophageal squamous dysplasia (ESD).7,8 Similar risk factors may affect the development of ESD and ESCC,9 including genetic susceptibility,10,11 environmental factors,12,13 drinking alcohol,14 smoking tobacco,14,15 opium consumption,15 drinking hot tea,16 low socioeconomic status17 and poor oral hygiene.18

One potentially effective method for controlling ESCC is to detect and eliminate ESD, preventing its progression into ESCC. This is the main aim of ESCC screening programs. Endoscopy with Lugol’s iodine staining of the esophageal mucosa, called Lugol’s chromoendoscopy, has been used in ESCC screening programs in different populations.1921 During chromoendoscopy, normal esophageal mucosa turns brown (iodine-positive) and dysplastic lesions remain unstained (iodine-negative), referred to as unstained lesions (USLs).

The Golestan Province, located in northeastern Iran, is a high-risk area for ESCC.4,22 Most ESCC cases present at advanced stage, resulting in a poor prognosis with a 5-year survival of only 3.3%23 Therefore, identification of earlier stage lesions by screening programs may potentially decrease the burden of this disease and improve health in this region. Endoscopic ESCC screening has been successfully conducted in several high-risk areas.24 As a first step in developing an early detection and treatment program in Golestan, the aims of this study were to assess the feasibility of a population-based endoscopic screening program and to document the prevalence and risk factor correlates of ESD in asymptomatic adults from the Golestan Province.

Materials and Methods

This was a cross-sectional study conducted on a randomly selected sample of asymptomatic participants of the Golestan Cohort Study (GCS). The design and methods of the GCS have been described elsewhere.25 Briefly, it is a prospective population-based cohort of 50,045 individuals, aged 40–75 years at baseline, in the eastern half of Golestan Province, Iran. It was primarily designed to investigate risk factors for upper gastrointestinal cancers.

For endoscopic screening, we aimed to randomly select about 300 GCS subjects, stratified on age group (<50, 50–70, >70 years) at GCS baseline (2004–2008), gender, and ethnicity (Turkmen or non-Turkmen). The first step of the screening project was telephone invitation. The initial telephone invitation lists included 2,000 randomly selected GCS participants. On telephone call, the aim of the study was explained briefly and the subjects were invited to participate. Subjects who accepted to participate in the study were picked up at their homes by drivers and taken to Atrak Clinic, a referral clinic for upper gastrointestinal diseases in eastern Golestan Province.

At Atrak Clinic, people with dysphagia, esophageal varices, cardiovascular disease, coagulopathies, severe pulmonary disease, cirrhosis of the liver, hypersensitivity to iodine solution, or a history of malignant disorders, myocardial infarction or stroke in the past 6 months were excluded. More detailed information about the project, including the procedures, risks, and benefits were provided to eligible subjects and informed consent was obtained. Subjects were then asked to complete a brief questionnaire including data on current age and gender. Detailed information about additional variables, including ethnicity (Turkmen, non-Turkmen), oral health, cooking methods, smoking, opium use, body mass index (BMI), tea temperature, and level of education, was obtained from the GCS main database. The methods of data collection in the GCS have been described previously.16,18,25

After completing the questionnaire, the subjects were transferred to the endoscopy room and administered Midazolam for sedation. Endoscopic examination of the esophagus, stomach and duodenum was performed, and 20cc of 1.4% Lugol’s iodine was sprayed on the esophageal mucosa to identify abnormal lesions. Biopsies were taken from all USLs and from two normally-stained sites in the mid-esophagus. Endoscopic findings were recorded on endoscopic exam forms. Endoscopic biopsies were oriented on filter paper, placed in 70% ethanol and transferred to the pathology lab. The biopsies were processed to paraffin blocks, slides were prepared and stained with hematoxylin and eosin, and the biopsies were reviewed by expert pathologists. Histological diagnosis was made using previously described criteria26 and the Vienna classification of gastrointestinal epithelial neoplasia.27 Subjects with clinically important lesions, including moderate and severe dysplasia, were evaluated further, and appropriate therapeutic procedures were provided.

Adverse events during the endoscopic examination were recorded and reported using structured adverse events forms. The subjects’ satisfaction with the endoscopic examination was assessed using a visual scale. Subjects were asked to select one of six scores, where 1 and 6 represented the best and worst satisfaction levels, respectively.

Based on their median current age, the participants were divided into younger (<53 years) and older (≥53 years) age groups. They were also divided by the median of decayed, missing and filled teeth (DMFT) into those with good (DMFT<17) and poor (DMFT≥17) oral health. BMI was used to categorize the participants into normal (BMI<25) and overweight/obese (BMI≥25) groups. USLs were classified as small (less than 5 mm) or large (equal or more than 5 mm) lesions.

Multivariate logistic regression analysis was used to assess the relationship between different variables and the worst biopsy diagnosis of esophagitis or esophageal squamous dysplasia. Crude and adjusted odds ratios with 95% confidence intervals were calculated. P values of less than 0.05 were considered significant.

The study protocol was reviewed and approved by the Ethics Committees of the Digestive Disease Research Institute (DDRI) of Tehran University of Medical Sciences (TUMS) and Golestan University of Medical Sciences (GOUMS).

Results

In total, 1906 GCS subjects were successfully called by telephone, 346 (18.2%) agreed to come to Atrak Clinic for endoscopic screening, and after exclusions, 302 subjects (15.8%) were successfully enrolled in the screening program. The 302 subjects participating in the screening had a mean age (±SD) of 54.8 (±7.7) years and a median age (range) of 53 (42–80) years. 128 (42.4%) were male, and 108 (35.8%) were of Turkmen ethnicity.

All 302 subjects completed the endoscopic screening exams successfully. Adverse events were reported in 8 subjects (2.6%), including agitation after Lugol’s staining (1 case), chest pain after endoscopy (1 case), vomiting after endoscopy (4 cases), and cutaneous rashes (2 cases). The adverse events were not clinically significant, and all of them were resolved without treatment. The majority of subjects were satisfied with the endoscopic examination: 52.3%, 34.1%, 8.9%, 3.0%, 1.7% and 0% of participants selected satisfaction levels 1, 2, 3, 4, 5, and 6, respectively.

USLs were found on endoscopic examination of 108 subjects (35.8%). The size of lesions was recorded in 100 of these subjects with USLs, including 41 subjects (41%) with only small (<5mm) USLs and 59 (59%) with at least one large (≥5mm) USL. In 66 (61.1%) of these 108 subjects, the USLs appeared as single lesions, and in 42 (38.9%), they were multiple. Most USLs (92.5%) were found in the middle and lower thirds of the esophagus.

The subjects’ worst histologic diagnoses are shown in Table 1. Esophagitis (29.5%) and ESD (6.0%) were the most common diagnoses. The distribution of ESD by age and gender is shown in Table 2. The prevalence of ESD increased with age and was similar in men and women. Out of the 18 subjects with ESD, none had dysplasia in the upper third, 16 (88.9%) had dysplasia in the middle third, and 2 (11.1%) had dysplasia in the lower third of the esophagus. The worst histologic diagnosis in four subjects was high-grade (moderate or severe) dysplasia, of whom three were female and their age ranged between 53 and 66 years.

Table 1.

The worst biopsy diagnosis of the 302 participants in the endoscopic screening study in the Golestan Province, Iran

Histological diagnosis Count Percentage
Normal 181 59.9
Basal cell hyperplasia 5 1.7
Mild Esophagitis 66 21.9
Moderate Esophagitis 16 5.3
Severe Esophagitis 7 2.3
Atypical changes indefinite for dysplasia 9 3.0
Mild Squamous Dysplasia 14 4.6
Moderate Squamous Dysplasia 2 0.7
Severe Squamous Dysplasia 2 0.7

Total 302 100.0

Table 2.

Number (N) and proportion (%) of participants with esophageal squamous dysplasia (ESD), by age and gender, in the endoscopic screening study in the Golestan Province, Iran

Age groups (years) Men Women Total

All ESD
N (%)
All ESD
N (%)
All ESD
N (%)
<50 31 1 (3.0) 54 2 (3.7) 85 3 (3.5)
50–59 55 3 (5.5) 84 4 (4.8) 139 7 (5.0)
60–69 33 3 (9.1) 29 3 (10.3) 62 6 (9.7)
≥70 9 0 (0.0) 7 2 (28.6) 16 2 (12.5)

Total 128 7 (5.5) 174 11 (6.3) 302 18 (6.0)

The correlation of the pathological diagnoses and the endoscopic appearances of the endoscopic biopsies sites is shown in Table 3. ESD was found in 15/76 (19.7%) of large USLs (≥5 mm), 0/55 (0.0%) of small USLs (<5 mm), and 10/299 (3.3%) of biopsies of normal-staining mucosa. The mean size of USLs was also significantly larger in lesions with a diagnosis of ESD (19.1±1.5 mm) than in those with a diagnosis of esophagitis (6.5±0.6 mm) or normal mucosa (6.8±1.0 mm) (P value<0.001). In the multivariate analysis, Turkmen ethnicity (adjusted OR=8.61; 95% CI: 2.48–29.83), being older than the median age (adjusted OR=7.7; 95% CI: 1.99–29.87) and using deep frying methods for cooking (adjusted OR=4.65; 95% CI: 1.19–18.22) were significantly associated with ESD (Table 4).

Table 3.

Correlation of the biopsy diagnoses and the Lugol’s staining patterns in 302 asymptomatic adults from the Golestan Province, Iran

Histological diagnosis Lugol’s staining pattern Total

Normal Staining Unstained Lesions (USLs)

Small* USLs Large* USLs

N % N % N % N %
Normal 216 72.2 34 61.8 32 42.1 282 65.6
Basal cell hyperplasia 2 0.7 2 3.6 3 3.9 7 1.6
Mild Esophagitis 56 18.7 11 20.0 15 19.7 82 19.1
Moderate Esophagitis 9 3.0 4 7.3 6 7.9 19 4.4
Severe Esophagitis 1 0.3 2 3.6 3 3.9 6 1.4
Atypical changes indefinite for dysplasia 5 1.7 2 3.6 2 2.6 9 2.1
Mild Squamous Dysplasia 7 2.3 0 0.0 10 13.2 17 4.0
Moderate Squamous Dysplasia 3 1.0 0 0.0 2 2.6 5 1.2
Severe Squamous Dysplasia 0 0.0 0 0.0 3 3.9 3 0.7

Total 299 100.0 55 100.0 76 100.0 430 100.0
*

Small USLs: < 5mm; Large USLs: >=5mm

Table 4.

Relationship between different variables and esophageal squamous dysplasia in asymptomatic adults from the Golestan Province, Iran

Variables Total number of subjects* Number (%) of subjects with dysplasia Univariate analysis Multivariate analysis

Crude OR 95% CI P-value Adjusted OR 95% CI P-value
Gender

 Male 128 7 (5.5) 0.76 0.16


 Female 174 11 (6.3) 1.17 0.44–3.10 2.89 0.65–12.87

Age group

 <53 years 145 4 (2.8) 0.03 0.003


 ≥53 years 157 14 (8.9) 3.45 1.28–12.75 7.70 1.99–29.87

Ethnicity

 Non-Turkmen 194 5 (2.6) 0.002 0.001


 Turkmen 108 13 (12) 5.66 1.11–10.74 8.61 2.48–29.83

Oral health

 Good 139 8 (5.8) 0.78 0.46


 Poor 153 10 (6.5) 1.14 0.44–2.99 0.65 0.21–2.03

Using deep frying method

 No 159 5 (3.1) 0.03 0.03


 Yes 133 13 (9.8) 3.34 1.16–9.62 4.65 1.19–18.22

Smoking

 No 239 15 (6.3) 0.87 0.95


 Yes 53 3 (5.7) 0.9 0.25–3.21 0.94 0.16–5.54

 Opium use

 No 260 16 (6.2) 0.98 0.66


 Yes 32 2 (6.2) 1.02 0.22–4.64 1.52 0.23–10.02

Body mass index

 Normal 78 5 (6.4) 0.92 0.78


 Overweight/obese 214 13 (6.1) 0.94 0.32–2.74 0.84 0.25–2.82

Tea temperature

 Cold 211 12 (5.7) 0.59 0.71


 Hot 81 6 (7.4) 1.33 0.48–3.66 1.25 0.39–4.04

Education

 None 100 7 (7.0) 0.79 - 0.14


 Primary school 72 5 (6.9) 0.99 0.30–3.26 4.58 0.88–23.77


 Secondary school or higher 120 6 (5.0) 0.70 0.23–2.15 5.31 0.85–33.23
*

Subjects with missing data were excluded

Most (82/107; 76.6%) of the esophagitis biopsies were graded as mild, and most (96/107; 89.7%) came from the middle third of the esophagus. About half (49.4%) of subjects with a worst pathologic diagnosis of esophagitis were male, and this diagnosis occurred most commonly in the 50–59 (48.3%) and 60–69 year (24.7%) age groups. There were also significant relationships between a worst diagnosis of esophagitis and smoking (adjusted OR=5.81; 95% CI: 2.43–13.88), drinking hot tea (adjusted OR=2.27; 95% CI: 1.15 – 4.47), and lack of education (secondary school education vs. none, adjusted OR=0.23; 95% CI: 0.09–0.56) (Table 5).

Table 5.

Relationship between different variables and esophagitis in asymptomatic adults from the Golestan Province, Iran

Variables Total number of subjects* Number (%) of subjects with esophagitis Univariate analysis Multivariate analysis

Crude OR 95% CI P-value Adjusted OR 95% CI P-value
Gender

 Male 119 44 (37.0) 0.21 0.94


 Female 151 45 (29.8) 0.72 0.43–1.20 1.03 0.50–2.12

Age group

 <53 years 134 37 (27.6) 0.06 0.57


 ≥53 years 136 52 (38.2) 1.62 0.97–2.70 1.19 0.65–2.20

Ethnicity

 Non-Turkmen 179 55 (30.7) 0.27 0.43


 Turkmen 91 34 (37.4) 1.34 0.79–2.28 1.28 0.69–2.37

 Oral health

 Good 128 32 (25.0) 0.007 0.20


 Poor 132 54 (40.9) 2.08 1.22–3.53 1.49 0.81–2.75

Using deep frying method

 No 144 46 (31.9) 0.66 0.17


 Yes 116 40 (34.5) 1.12 0.67–1.88 0.64 0.34–1.21

Smoking

 No 211 58 (27.5) <0.001.00 <0.001


 Yes 49 28 (57.1) 3.52 1.85–6.68 5.81 2.43–13.88

Opium Use

 No 232 74 (31.9) 0.25 0.51


 Yes 28 12 (42.9) 1.60 0.72–3.56 0.73 0.28–1.89

Body mass index

 Normal 69 22 (31.9) 0.81 0.09


 Overweight/obese 191 64 (33.5) 1.08 0.60–1.94 1.84 0.91–3.72

Tea temperature

 Cold 191 59 (30.9) 0.21 0.02


 Hot 69 27 (39.1) 1.44 0.81–2.55 2.27 1.15–4.47

Education

 None 89 39 (43.8) 0.03 0.004


 Primary school 63 18 (28.6) 0.51 0.26–1.02 0.37 0.16–0.85


 Secondary school or higher 108 29 (26.9) 0.47 0.26–0.86 0.23 0.09–0.56
*

Subjects with missing data were excluded

The endoscopic examinations showed hiatal hernia in 39 subjects (12.9%). Gastroesophageal reflux disease (GERD) was reported in 28.2% and 4.9% of subjects with and without hiatal hernia, respectively (P value<0.001). The prevalence of hiatal hernia was significantly higher in subjects of Turkmen ethnicity (18.5%) than in non-Turkmens (9.8%; P value=0.03). The prevalence of GERD was also higher in Turkmen (12.0% vs. 6.7%; P value=0.08). No significant relationship was found between the presence of hiatal hernia or GERD and other variables including age, gender, ethnicity, BMI or smoking.

Discussion

Esophageal squamous cell carcinoma (ESCC) is a common fatal cancer across central Asia, including the Golestan Province, Iran. The high fatality rate of this cancer is largely due to the late development of symptoms, which leads to late diagnosis, after the tumor has spread outside the esophagus. One potential way to reduce mortality from such a cancer is earlier diagnosis of the tumor or its precursor lesions, when the disease is still curable. For ESCC, in which nearly all early lesions are asymptomatic, this will require screening asymptomatic high-risk people. The only screening technique to date that has shown a high sensitivity for identifying esophageal squamous dysplasia (ESD), the precursor lesion of ESCC, in asymptomatic people is Lugol’s chromoendoscopy. The aims of this study were to evaluate the feasibility of this technique and to document the prevalence and risk factor correlates of ESD among asymptomatic adults in the Golestan Province.

Only 18.2% of this representative sample of the general population of eastern Golestan Province agreed to be screened by endoscopy, and after ineligible subjects were excluded, only 15.8% of the originally invited subjects underwent endoscopy. Endoscopic examination is an invasive procedure; therefore, this low compliance rate is not too surprising in a general population, especially in response to a single telephone invitation. This procedure may be more acceptable to subgroups of individuals who are persuaded that they have an exceptionally high risk for developing ESCC, such as patients with a previous head and neck cancer, 20 alcoholic subjects, 28 or others shown to be at especially high risk by other risk-stratification models. 9, 29 Concentrating the risk in such ways should also increase the proportion of screened subjects with ESD lesions. Of note in our study, once subjects were enrolled in the screening program, they all completed endoscopy, there were no significant adverse events, and most were quite satisfied with their experience.

The prevalence of ESD in our study was only 6.0%, including 4.6% of participants with low-grade (mild) dysplasia and 1.4% with high-grade (moderate or severe) dysplasia. Three previous papers have reported much higher rates of total ESD (21.5% – 31.6%) and high-grade ESD (12.9% – 17.5%) from high-risk areas of China. 24, 30, 31 These differences probably reflect differences in ESCC rates among the screened populations.

Our results showed a positive correlation between the prevalence of ESD and the participants’ age, and a similar prevalence in men and women. This data will inform the design of future screening efforts in this population, which may include only older adults (e.g. subjects older than 50 years).

The correlation of biopsy diagnoses and Lugol’s staining pattern was consistent with the mechanism of Lugol’s staining and the results of previous studies. Iodine reversibly binds to glycogen, which is abundant in normal superficial squamous epithelial cells but is scant in rapidly-dividing cells such as those in high-grade esophagitis or dysplasia. Thus, most biopsies that were histologically normal or showed mild esophagitis came from mucosa that appeared brown after application of Lugol (normally stained), while most biopsies of higher-grade esophagitis or dysplasia came from USLs. These findings were similar to those in previous reports. 32

We also found a significant relationship between the size of USLs and the histologic diagnosis of their biopsies. All biopsies from USLs that showed dysplasia came from USLs ≥5mm in greatest dimension. This result confirms the rationale for the practice of previous authors who only biopsied USLs ≥ 5mm in size. 28, 33

The prevalence of ESD was significantly higher in older subjects, Turkmens, and those who used deep frying methods for cooking. Genetic susceptibility has been suggested as a risk factor for ESD and ESCC in previous studies, 10, 11, 34 and Akbari et al reported a strong familial component to ESCC among Turkmens. 35 In addition, Hakami et al reported an increased risk of ESCC among subjects from this region who use deep frying to cook their food. 36 Thus, these results from our study are in line with previous reports suggesting that risk factors for ESD are similar to those for ESCC.9 However, we found no significant relationship between ESD and other variables that have been reported as risk factors for ESCC in northern Iran, including smoking tobacco, 15 opium consumption, 15 drinking hot tea, 16 poor oral health, 18 and low socioeconomic status. 17 This may be due to the small number of ESD lesions found in our study, and the resulting low power of our study to detect such associations.

Esophagitis was the most common abnormal pathology in our subjects, and was the worst histologic diagnosis in 29.5%. Over 75% of the esophagitis biopsies were graded as mild, similar to previous esophageal screening studies. 24, 30, 31 We found a significant relationship between smoking tobacco, drinking hot tea and lack of education and the risk of esophagitis. These variables have also been suggested as risk factors for ESCC in our region. 1517

In our study, the prevalence of hiatal hernia and GERD were approximately twice higher in Turkmen than non-Turkmen subjects. Recently, an increasing rate of esophageal adenocarcinoma was reported in the Golestan Province. 37 In addition, Ehsani et al have reported a high frequency of GERD in another Iranian population. 38 Additional studies of trends in GERD, Barrett’s esophagus and esophageal adenocarcinoma, both in Golestan and throughout Iran, are warranted.

In conclusion, we found a low compliance rate for endoscopic screening and a low prevalence of esophageal squamous dysplasia among asymptomatic adults in the Golestan Province, suggesting the need for developing less invasive non-endoscopic methods for primary ESCC screening which can accurately triage the highest-risk individuals to endoscopy. Risk-stratification by genetic or environmental risk factors may also improve the yield of such a screening program.

Acknowledgments

The authors would like to thank Dr. Sharifi, Ms. Kor, Dr. Khalilipour, Dr. Abaie, Mr. Yolmeh, Mr. Ataie, Mrs. Nasi and Mrs. Mohammadi for their valuable work in data collection and sample processing. This study was supported by the Digestive Disease Research Institute (DDRI) affiliated with Tehran University of Medical Sciences (TUMS); the Golestan Research Center of Gastroenterology and Hepatology (GRCGH) affiliated with Golestan University of Medical Sciences (GOUMS); and in part by the Intramural Research Program of the National Cancer Institute, NIH.

References

  • 1.Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon: International Agency for Research on Cancer; 2010. [03/02/2011]. Available from: URL: http://globocan.iarc.fr. [Google Scholar]
  • 2.Bird-Lieberman EL, Fitzgerald RC. Early diagnosis of oesophageal cancer. Br J Cancer. 2009;101:1– 6. doi: 10.1038/sj.bjc.6605126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Das A. Tumors of the Esophagus. In: Feldman M, Friedman L, Brandt LJ, editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9. Vol. 1. Philadelphia: Saunders Elsevier; 2010. pp. 745–770. [Google Scholar]
  • 4.Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S. Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer. 1973;28:197– 214. doi: 10.1038/bjc.1973.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Islami F, Kamangar F, Nasrollahzadeh D, Moller H, Boffeta P, malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - A review. Eur J Cancer. 2009;45:3156– 3165. doi: 10.1016/j.ejca.2009.09.018. [DOI] [PubMed] [Google Scholar]
  • 6.Kamangar F, Malekzadeh R, Dawsey SM, Saidi F. Esophageal cancer in Northeastern Iran: a review. Arch Iran Med. 2007;10:70– 82. [PubMed] [Google Scholar]
  • 7.Dawsey SM, Lewin KJ, Wang GQ, Liu FS, Nieberg RK, Yu Y, et al. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer. 1994;74:1686– 1692. doi: 10.1002/1097-0142(19940915)74:6<1686::aid-cncr2820740608>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  • 8.Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut. 2005;54:187– 192. doi: 10.1136/gut.2004.046631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wei WQ, Abnet CC, Lu N, Roth MJ, Wang GQ, Dye BA, et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut. 2005;54:759– 763. doi: 10.1136/gut.2004.062331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Akbari M, Malekzadeh R, Lepage P, Roquis D, Sadjadi A, Aghcheli K, et al. Mutations in Fanconi anemia genes and the risk of esophageal cancer. Hum Genet. 2011;129:573– 582. doi: 10.1007/s00439-011-0951-7. [DOI] [PubMed] [Google Scholar]
  • 11.Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, et al. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene. 2007;27:1290– 1296. doi: 10.1038/sj.onc.1210739. [DOI] [PubMed] [Google Scholar]
  • 12.Abedi-Ardekani B, Kamangar F, Hewitt SM, Hainaut P, Sotoudeh M, Abnet CC, et al. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut. 2010;59:1178– 1183. doi: 10.1136/gut.2010.210609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Semnani S, Roshandel G, Zendehbad A, Keshtkar A, Rahimzadeh H, Abdolahi N, et al. Soils selenium level and esophageal cancer: An ecological study in a high risk area for esophageal cancer. J Trace Elem Med Biol. 2010;24:174– 177. doi: 10.1016/j.jtemb.2010.03.002. [DOI] [PubMed] [Google Scholar]
  • 14.Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165:1424– 1433. doi: 10.1093/aje/kwm051. [DOI] [PubMed] [Google Scholar]
  • 15.Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer. 2008;98:1857– 1863. doi: 10.1038/sj.bjc.6604369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ. 2009;338:b929. doi: 10.1136/bmj.b929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol. 2009;38:978– 988. doi: 10.1093/ije/dyp195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, et al. Tooth Loss and Lack of Regular Oral Hygiene Are Associated with Higher Risk of Esophageal Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17:3062– 3068. doi: 10.1158/1055-9965.EPI-08-0558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Freitag CP, Barros SG, Kruel CD, Putten AC, Dietz J, Gruber AC, et al. Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern Brazil. Dis Esophagus. 1999;12:191– 195. doi: 10.1046/j.1442-2050.1999.00046.x. [DOI] [PubMed] [Google Scholar]
  • 20.Hashimoto CL, Iriya K, Baba ER, Navarro-Rodriguez T, Zerbini MC, Eisig JN, et al. Lugol’s Dye Spray Chromoendoscopy Establishes Early Diagnosis of Esophageal Cancer in Patients with Primary Head and Neck Cancer. Am J Gastroenterol. 2005;100:275– 282. doi: 10.1111/j.1572-0241.2005.30189.x. [DOI] [PubMed] [Google Scholar]
  • 21.Meyer V, Burtin P, Bour B, Blanchi A, Cales P, Oberti F, et al. Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? Gastrointest endosc. 1997;45:480– 484. doi: 10.1016/s0016-5107(97)70177-9. [DOI] [PubMed] [Google Scholar]
  • 22.Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat S, Nouraie S, et al. Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008. Arch Iran Med. 2012;15:196– 203. [PubMed] [Google Scholar]
  • 23.Aghcheli K, Marjani HA, Nasrollahzadeh D, Islami F, Shakeri R, Sotoudeh M, et al. Prognostic factors for esophageal squamous cell carcinoma--a population-based study in Golestan Province, Iran, a high incidence area. PLoS ONE. 2011;6:e22152. doi: 10.1371/journal.pone.0022152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lu XJ, Chen ZF, Guo CL, Li SS, Bai WL, Jin GL, et al. Endoscopic survey of esophageal cancer in a high-risk area of China. World J Gastroenterol. 2004;10:2931– 2935. doi: 10.3748/wjg.v10.i20.2931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, et al. Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol. 2010;39:52– 59. doi: 10.1093/ije/dyp161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dawsey SM, Lewin KJ, Liu FS, Wang GQ, Shen Q. Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Cancer. 1994;73:2027– 2037. doi: 10.1002/1097-0142(19940415)73:8<2027::aid-cncr2820730803>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  • 27.Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251– 255. doi: 10.1136/gut.47.2.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yokoyama A, Ohmori T, Makuuchi H, Maruyama K, Okuyama K, Takahashi H, et al. Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer. 1995;76:928– 934. doi: 10.1002/1097-0142(19950915)76:6<928::aid-cncr2820760604>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  • 29.Etemadi A, Abnet CC, Golozar A, Malekzadeh R, Dawsey SM. Modeling the risk of esophageal squamous cell carcinoma and squamous dysplasia in a high risk area in Iran. Arch Iran Med. 2012;15:18– 21. [PMC free article] [PubMed] [Google Scholar]
  • 30.Pan QJ, Roth MJ, Guo HQ, Kochman ML, Wang GQ, Henry M, et al. Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Llinxian, China. Acta Cytol. 2008;52:14– 23. doi: 10.1159/000325430. [DOI] [PubMed] [Google Scholar]
  • 31.Roth MJ, Liu S-F, Dawsey SM, Zhou B, Copeland C, Wang G-Q, et al. Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer. 1997;80:2047– 2059. doi: 10.1002/(sici)1097-0142(19971201)80:11<2047::aid-cncr3>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  • 32.Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer. 1998;83:220– 231. [PubMed] [Google Scholar]
  • 33.Limburg PJ, Wei W, Ahnen DJ, Qiao Y, Hawk ET, Wang G, et al. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology. 2005;129:863– 873. doi: 10.1053/j.gastro.2005.06.024. [DOI] [PubMed] [Google Scholar]
  • 34.Zhou YZ, Diao YT, Li H, Li HQ, Ma Q, Cui J. Association of genetic polymorphisms of aldehyde dehydrogenase-2 with esophageal squamous cell dysplasia. World J Gastroenterol. 2010;16:3445– 3449. doi: 10.3748/wjg.v16.i27.3445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Akbari MR, Malekzadeh R, DN Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer. 2006;119:1047– 1051. doi: 10.1002/ijc.21906. [DOI] [PubMed] [Google Scholar]
  • 36.Hakami R, Etemadi A, Kamangar F, Pourshams A, Mohtadinia J, Firoozi MS, et al. Cooking Methods and Esophageal Squamous Cell Carcinoma in High-Risk Areas of Iran. Nutr cancer. 2013 doi: 10.1080/01635581.01632013.01779384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ghasemi-Kebria F, Roshandel G, Semnani S, Shakeri R, Khoshnia M, Naeimi-Tabiei M, et al. Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer. Arch Iran Med. 2013;16:320– 323. [PubMed] [Google Scholar]
  • 38.Ehsani MJ, Maleki I, Mohammadzadeh F, Mashayekh A. Epidemiology of gastroesophageal reflux disease in Tehran, Iran. J Gastroenterol Hepatol. 2007;22:1419– 1422. doi: 10.1111/j.1440-1746.2006.04616.x. [DOI] [PubMed] [Google Scholar]

RESOURCES